SDZ-NVI-085

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSDZ-NVI-085
Drug Alias NameSDZ-NVI-085
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 agonists
TargetsAdrenergic receptors alpha-1
Therapy Area/IndicationsCognition DisordersDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsCognition DisordersDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksN/A